Found: 34
Select item for more details and to access through your institution.
Intra-CSF administration of chemotherapy medications.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 1, doi. 10.1007/s00280-012-1893-z
- By:
- Publication type:
- Article
Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Tumor and non-tumor tissues differential oxidative stress response to supplemental DHA and chemotherapy in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 17, doi. 10.1007/s00280-012-1884-0
- By:
- Publication type:
- Article
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 25, doi. 10.1007/s00280-012-1883-1
- By:
- Publication type:
- Article
Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 33, doi. 10.1007/s00280-012-1885-z
- By:
- Publication type:
- Article
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 39, doi. 10.1007/s00280-012-1882-2
- By:
- Publication type:
- Article
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 49, doi. 10.1007/s00280-012-1887-x
- By:
- Publication type:
- Article
Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 57, doi. 10.1007/s00280-012-1870-6
- By:
- Publication type:
- Article
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 65, doi. 10.1007/s00280-012-1880-4
- By:
- Publication type:
- Article
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 75, doi. 10.1007/s00280-012-1891-1
- By:
- Publication type:
- Article
Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children's oncology group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 83, doi. 10.1007/s00280-012-1878-y
- By:
- Publication type:
- Article
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 95, doi. 10.1007/s00280-012-1889-8
- By:
- Publication type:
- Article
Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 103, doi. 10.1007/s00280-012-1888-9
- By:
- Publication type:
- Article
Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 113, doi. 10.1007/s00280-012-1890-2
- By:
- Publication type:
- Article
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
- Published in:
- 2012
- By:
- Publication type:
- journal article
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 121, doi. 10.1007/s00280-012-1894-y
- By:
- Publication type:
- Article
The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 129, doi. 10.1007/s00280-012-1867-1
- By:
- Publication type:
- Article
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 141, doi. 10.1007/s00280-012-1895-x
- By:
- Publication type:
- Article
Comparison of a homologous series of benzonaphthyridine anti-cancer agents in mice: divergence between tumour and plasma pharmacokinetics.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 151, doi. 10.1007/s00280-012-1892-0
- By:
- Publication type:
- Article
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 161, doi. 10.1007/s00280-012-1896-9
- By:
- Publication type:
- Article
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 169, doi. 10.1007/s00280-012-1901-3
- By:
- Publication type:
- Article
The minimal impact of food on the pharmacokinetics of ridaforolimus.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
The minimal impact of food on the pharmacokinetics of ridaforolimus.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 177, doi. 10.1007/s00280-012-1897-8
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers.
- Published in:
- 2012
- By:
- Publication type:
- Report
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor.
- Published in:
- 2012
- By:
- Publication type:
- Report
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 201, doi. 10.1007/s00280-012-1859-1
- By:
- Publication type:
- Article
The 'survivin suppressants' NSC 80467 and YM155 induce a DNA damage response.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 207, doi. 10.1007/s00280-012-1868-0
- By:
- Publication type:
- Article